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Ablation of renal mass is followed by hypertrophy and
hyperplasia of the remaining kidney tissue. A great deal of
information has been accumulated regarding the biochemical
and morphological changes that accompany this so-called
"compensatory" renal growth [11. However, the stimulus, or
signal, for this growth remains to be identified. The kidneys are
responsible for diverse functions—excretory, metabolic, and
hormonal—and the reduction of one or a combination of these
functions that follows reduction of renal mass probably pro-
vides the signal for growth of the remnant kidney tissue.
We have reported evidence that a selective reduction in renal
excretory function, or the circulatory retention of factors ex-
creted in the urine, is capable of stimulating renal growth. This
evidence has been derived from an experimental model that
consists of a rat in which half the urine output of both kidneys is
constantly reinfused intravenously [2, 3]. Urinary excretion is,
in effect, halved by this procedure of "half-urine-reinfusion,"
without reduction of renal mass or nonexcretory renal
functions.
Rats subjected to half-urine-reinfusion for 24 hr have exhibit-
ed significant increases in wet kidney weight, total renal protein
content, the incorporation of leucine into renal protein, and the
cellular uptake of leucine by renal cortex [3]. Dialysis of the
urine before reinfusion did not diminish the stimulation of
leucine incorporation into renal protein. Furthermore, hepatic
protein content was not increased by haif-urine-reinfusion,
indicating some degree of specificity of growth stimulation for
the kidneys [3]. These results have suggested that retention in
the circulation of poorly dialyzable renal growth-stimulating
factors that are normally excreted in the urine is capable of
stimulating renal growth. It appears possible that retention of
these "renotrophic" factors may play a role in the stimulation
of renal growth following renal ablation.
The purpose of the present report is to describe evidence that
urinary renotrophic activity can be transferred from one rat to
another; that it stimulates synthesis of renal DNA and phospho-
lipid as well as protein that it is synthesized at a site(s) other
than the kidney itself; and that it acts, at least in part, by direct
stimulation of the kidney tissue.
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Methods
Male Sprague-Dawley rats (Charles River Breeding Labora-
tories, Wilmington, Massachusetts) weighing 175 to 225 g were
used in all studies.
Three types of studies are described herein. In the first, rats
were subjected to half-urine-reinfusion for 24 hr to determine
the effects of this procedure on renal DNA synthesis. In the
second, a bioassay system for urinary renotrophic activity was
used. Urine was collected from "donor" rats. The ability of this
urine, or fractions thereof, to stimulate renal growth when
infused intravenously into "recipient" assay rats was studied,
using the renal synthesis of either DNA or phospholipid as an
index of growth. In the third, isolated renal cortical tissue was
incubated with an ultrafiltration retentate of urine, and the
effect of this treatment on phospholipid synthesis, as an index
of growth stimulation, was examined.
Haif-urine-reinfusion studies. These studies were designed so
that experimental animals (½UR) were paired for comparison
with sham-manipulated control rats (sham) that were weight-
matched littermates. Eighteen such pairs were studied. The
animals were anesthetized briefly with ether to permit surgical
implantation of polyethylene catheters in the urinary bladder
and a femoral vein. After surgery, each rat was placed in a
restraining cage for a 24-hr period. During this period, one
member of each pair was subjected to the constant intravenous
reinfusion of half of its urine output, using a servo-activated
pump apparatus. All rats were given a continuous intravenous
infusion of a solution containing 0.225% sodium chloride, 3%
dextrose, and chloramphenicol (Chloromycetin Sodium Succi-
nate, Parke, Davis, Detroit, Michigan) I mg/mI at the rate of 150
mi/kg body weight per 24 hr. The methods and apparatus far
these experiments have been described previously in detail [31.
At the end of the 24-hr period, each animal was anesthetized,
and the left kidney was removed for determination of either
whole-kidney DNA content (ten pairs) or the incorporation rate
of tritiated thymidine into cortical DNA in vitro (eight pairs).
These methods are described below.
Rat bioassay studies. Urine samples to be assayed were
collected from conscious "donor" rats, which had implantation
of bladder and venous catheters as described above. Urine from
the bladder catheter was collected into a flask immersed in ice
for a 24-hr period. During this period, each rat was given an
intravenous infusion of 0.45% sodium chloride at the rate of 150
ml/kg per 24 hr. Particulate matter in the urine was removed by
centrifugation. The urine was then either assayed without
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modification, or modified by procedures such as fractionation
or heating.
The entire volume of each 24-hr urine sample, or fraction
derived therefrom, was infused intravenously into a conscious
"recipient" assay rat over a 24-hr period, using a refrigerated
syringe pump [2]. A solution of 0.45% sodium chloride was
added to the urine sample such that the total volume infused
was 150 mllkg of the recipient's body weight. For comparison, a
matched littermate of the assay rat was infused simultaneously
with an equal volume of 0.45% sodium chloride. At the end of
the 24-hr infusion period, each rat was anesthetized, and the left
kidney was removed for determination of either the incorpo-
ration rate of thymidine into renal DNA in vitro or the cellular
uptake of thymidine by renal cortex in vitro, as described
below. In one group of assay rats, the liver was removed for
determination of thymidine incorporation into hepatic DNA.
In a separate group of experiments, donor rats were used in
pairs. One of the pair underwent unilateral nephrectomy, and
the other had a sham nephrectomy. Urine collection from both
rats was then either begun immediately (eight pairs), or collec-
tion was delayed for 24 hr (nine pairs), 48 hr (eight pairs), or 72
hr (seven pairs). Each collection was for 24 hr. The urine
samples from the paired donors were assayed simultaneously in
a pair of assay rats, one receiving urine from the nephrectomy
(one-kidney) donor, and the other receiving urine from the
sham (two-kidney) donor.
The incorporation of radiolabelled choline into renal phos-
pholipid in vitro was determined in a separate group of assay
studies, using urine from two-kidney donors. In these studies,
one eighth of an entire 24-hr urine collection (that is, a 3-hr
aliquot) was infused into an assay rat over a 3-hr period. At the
end of this period, the left kidney was removed for the
determination of choline incorporation.
Studies using isolated renal tissue. In these studies, we
specifically examined the fraction of urine retained on an
ultrafiltration membrane with a nominal solute rejection of
50,000 daltons (XM5O Diaflo, Amicon Corporation, Lexington,
Massachusetts). This retentate, which had been noted to be the
most active stimulator of renal phospholipid synthesis when
infused into assay rats (see below), was incubated with isolated
renal cortical fragments to test its ability to directly stimulate
phospholipid synthesis in renal tissue.
Thymidine incorporation into renal DNA. At the end of the
24-hr periods of either half-urine-reinfusion, or urine infusion in
the assay studies, the left kidney was removed, and cortical
fragments were prepared from inner cortical slices as described
previously [3]. The fragments were initially pre-incubated for 30
mm in Krebs-Ringer-bicarbonate medium, pH 7.4, containing
10 M thymidine, at 37°C under 95% 02, 5% CO2 in a metabolic
shaker. Following this pre-incubation, [methyl-3H1 thymidine
(Amersham, Arlington Heights, Illinois) was added to each vial
to yield 8.3 mCi/i.tmole specific activity, and incubation was
continued for an additional 90 mm. No significant change in
thymidine concentration of the medium occurred during incuba-
tion. Following incubation, the cortical fragments were separat-
ed from the medium, homogenized in water, and the specific
activity of DNA in the homogenate was determined, using a
method described previously for measuring protein specific
activity [31. DNA concentration in the homogenate was mea-
sured by the diphenylamine method, as described by Giles and
Myers [41. The incorporation rate of tritiated thymidine into
DNA was calculated as counts per minute (cpm) per microgram
of DNA per hour of incubation. In preliminary experiments,
thymidine incorporation was found to increase as a linear
function of time over a 90-mm incubation period. In some
experiments, these same methods were used to determine the
incorporation of tritiated thymidine into hepatic DNA in vitro.
Total renal DNA content was determined in 10 pairs of rats
('/2UR rats paired with sham rats). In these studies, the left
kidney was stripped of its capsule, weighed, and homogenized.
DNA concentration in the homogenate was measured as above.
The cellular uptake of thymidine by renal cortical tissue in
vitro was examined, using methods described previously for
measuring the cellular uptake of leucine [31 in seven pairs of
rats. These were assay rats that had received an infusion of a
donor rat's urine over a 24-hr period, paired with saline-infused
control rats. Cortical fragments were incubated as above with
tritiated and nonradioactive thymidine, along with [14C]-inulin
as a marker of extracellular fluid space, for periods of 5, 10, 30,
and 60 mm. The fragments were homogenized in 10% trichloro-
acetic acid, and the intracellular acid-soluble thymidine concen-
tration (cpm per mg cellular mass) was compared with that of
the medium.
Choline incorporation into renal phospholipid. After a 3-hr
period of infusion with either whole urine or fractions thereof,
the left kidney was removed, and the incorporation rate of
['4C]-choline into phospholipid in cortical tissue was examined,
using a modification of techniques described by Toback, Smith,
and Lowenstein [5]. Cortical fragments were incubated for 30
mm in Krebs-Ringer-bicarbonate under standard metabolic
conditions as described above, the medium containing 20 /LM
choline chloride, with [methyl-'4C] choline chloride (New En-
gland Nuclear Corporation, Boston, Massachusetts) to yield 4.1
mCilmmole sp act. The tissue fragments were then separated
from the medium, rinsed with 0.9% sodium chloride containing
1% nonradioactive choline chloride, and homogenized in 0.9%
sodium chloride. Protein concentration of the homogenate was
measured with the Coomassie Brilliant Blue G-250 method
(Bio-Rad Laboratories, Richmond, California). Phospholipids
in the homogenate were extracted with chloroform-methanol
2:1 (v/v) as described by Folch, Lees, and Stanley [61. Radioac-
tivity in the organic phase containing the phospholipids was
measured by liquid scintillation counting, and the incorporation
of choline was calculated as cpm per mg protein per 30 mm of
incubation.
In studies in which the ability of a urine fraction to directly
stimulate phospholipid synthesis in isolated kidney tissue was
examined, normal rats were anesthetized with ether, and both
kidneys were removed. Cortical fragments were obtained as
above and transferred to Krebs-Ringer-bicarbonate medium
containing 20 M choline chloride, along with varying concen-
trations of urine XM5O ultrafiltration retentate (nominally great-
er than 50,000 daltons). The concentration of retentate was
calculated as the duration of the urine collection time (mm)
represented in the quantity of urine from which the retentate
was derived, per milliliter of incubation medium. The tissue was
incubated under standard metabolic conditions for 90 mm, after
which ['4C]-choline was added, and incubation was continued
for an additional 30 mm. At the end of this period, the
incorporation of '4C into phospholipid per milligram of protein
was determined as above.
Characterization studies. Fractionation of urine by ultrafil-
t
.
Fig. 1. Left panel: Rates of incorporation of tritiated thymidine into
renalcortical DNA in vitro in 22 matched littermate pairs of assay rats,
which had received an intravenous infusion of either saline or urine for
24 hr. Lines connect members of each pair. Arrows indicate the means.
The increase in the urine-infused rats was significant (P < 0.00 1). Right
panel: these same results as the ratio of the urine-in fused:saline-infused
incorporation rates.
tration was performed at 4°C using a stirred cell (Model 52,
Amicon Corporation), pressurized with nitrogen gas at 1 kg!
cm2. The filtrate through an XM5O membrane was refractionat-
ed using a UM1O membrane (nominal solute rejection 10,000
daltons).
The effect of heating urine on its ability to stimulate thymi-
dine incorporation into renal DNA in assay rats was examined.
The 24-hr urine collections from two different donor rats were
pooled and then redivided into two equal portions, one of which
was heated to 100°C by immersing the tube containing the urine
in boiling water for 30 mm. The other portion was not heated.
The two portions were infused simultaneously into separate
assay rats, along with a third saline-infused control rat.
Statistics were calculated as described by Steel and Tonic
[71. Paired and unpaired Student's t tests were used as appropri-
ate to compare group means. Values are presented as means
SEM.
Results
Haif-urine-reinfusion. Eighteen 1/sUR rats underwent intrave-
nous reinfusion of half their urine for 24 hr, each rat being
paired for comparison with a sham-manipulated littermate. In
ten of these pairs, wet kidney weight and whole-kidney DNA
were measured. Mean body weight of the sham rats (182 5 g)
was slightly, although not significantly, greater than that of the
'/2UR rats (176 3 g). Kidney weight was increased in the '/2UR
rats (841 38 mg for 1/2UR vs. 767 35 for sham, P < 0.02), as
was DNA content per kidney (3.82 0.19 mg for V2UR vs. 3.51
0.17 for sham, P < 0.05).
The incorporation of tritiated thymidine into renal DNA in
vitro was determined in eight of the above pairs and was found
to be consistently and markedly increased in the '/2UR rats.
Incorporation rates were 63.6 12.6 cpm per tg DNA per hr
incubation for 1/2UR, compared with 30.1 5.6 for sham (P <
0.0 1).
Rat bioassay, thymidine incorporation. Twenty-two assay
rats received, over a 24-hr period, an intravenous infusion of
the urine collected for 24 hr from donor rats. Each urine-infused
assay rat was paired for comparison with a matched littermate
that was infused simultaneously with saline. As shown in Figure
1, thymidine incorporation into renal cortical DNA in vitro was
increased in the urine-infused member of the pair in 21 of the 22
assays; the mean incorporation in the urine-infused rats was
approximately twice that of the saline-infused rats (P < 0.00 1).
In the right-hand panel of Figure 1, these same results are
depicted as the ratio of the urine-infused:saline-infused incorpo-
ration rates, a value greater than unity indicating stimulation of
thymidine incorporation by urine-infusion.
In seven urine-infused assay rats, each paired with a saline-
infused control, the effects of urine-infusion on the in vitro
cellular uptake of thymidine by renal cortical tissue were
examined. In Figure 2, the intracellular concentrations of
tritiated thymidine, expressed as cell-to-medium distribution
ratio, are depicted as a function of time of incubation. There
were no significant differences between the two models at any
of the times examined. The intracellular levels of thymidine in
both models approached plateau levels by 30 mm of incubation,
although in neither model was a plateau clearly achieved by 60
mm.
The effects of 24 hr of urine-infusion on thymidine incorpo-
ration into hepatic DNA was evaluated in six assay rats. In
these studies, liver tissue (fragments of liver slices) was incu-
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Fig. 2. Cellular uptake of tritiated thymidine in vitro by renal cortical
tissue in seven matched pairs of urine-infused and saline-infused rats.
The differences between the two groups are not significant at any time
period.
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Fig. 3. Effect of heating urine to 100°C for 30 mm on its ability to
stimulate thymidmne incorporation into renal DNA in rat bioassay.
Arrows indicate the means. The reduction in activity due to heating was
significant (P < 0.001).
bated with tritiated thymidine, as described above for kidney
tissue. There was virtually no difference between hepatic
thymidine incorporation in the urine-infused rats (47.1 9.2
cpm4g DNAIhr) and the saline-infused controls (47.6 8.6).
Effect of heating urine on thymidine incorporation. Seven
assay rats received an infusion of urine that had been heated
previously to 100°C for 30 mm. Each of these rats was studied
simultaneously with both a rat infused with unheated urine and
with a saline-infused control. As shown in Figure 3, the rats
infused with both heated and with unheated urine displayed
significant stimulation of renal thymidine incorporation (P <
0.01). In each assay, the activity of the heated urine was
somewhat less than that of the unheated urine, the overall
reduction being about 21% (P < 0.001).
Effects of ultrafiltration of urine on thymidine incorporation.
Urine fractions prepared by ultrafiltration were infused into
assay rats, and their ability to stimulate renal DNA thymidine
incorporation was examined. As shown in Figure 4, consistent
and significant stimulatory activity was demonstrable both in
the fraction retained on an XM5O membrane (nominally greater
than 50,000 daltons) and in the fraction that passed through an
XM5O but was retained on a UM1O membrane (nominally
between 10,000 and 50,000 daltons). Mean activity in the former
fraction was somewhat greater than that in the latter fraction,
though this difference was not significant. No significant activi-
Fig. 4. Stimulation of thymidmne incorporation into renal DNA in rat
bioassay by various ultrafiltration fractions of urine. Molecular sizes
refer to the nominal solute rejection specified for the UM1O and XM5O
membranes. Arrows indicate the means. P values refer to the differ-
ences between urine-infused and saline-infused means.
ty was evident in the fraction nominally below 10,000 daltons
(UM1O filtrate).
Effects of uninephrectomy on urinary excretion of renotroph-
ic activity. In these studies, urine was collected from donor rats
that were paired, one member having a uninephrectomy and the
other a sham nephrectomy. Urine was either collected immedi-
ately after surgery, or collections were delayed for various
lengths of time. These samples were infused into assay rats,
whose incorporation of tritiated thymidine into renal DNA was
then measured. The results are shown in Figure 5, expressed as
the ratio of the response in the assay rat that received urine
from the one-kidney (uninephrectomy) donor to that of the
assay rat that received urine from the two-kidney (sham) donor.
This ratio was less than one during the first 2 days, indicating
that urine from a one-kidney donor had a decreased ability to
stimulate renal thymidine incorporation compared with urine
from a two-kidney donor, for the first 2 days after nephrectomy.
These decreases, 21% at 0 to 24 hr and 20% at 24 to 48 hr, were
both significant. After 48 hr, urine from one-kidney donors was
virtually the same as that from two-kidney donors in its ability
to stimulate thymidine incorporation.
Rat bioassay, choline incorporation. In seven assays, rats
were infused with urine for 3 hr; the amount of urine infused in
each rat was a 3-hr aliquot of a 24-hr collection. At the end of
the infusion, the incorporation rate of ['4C]-choline into renal
cortical phospholipid in vitro was determined. In comparison
with saline-infused control rats, the urine-infused assay rats
exhibited significantly increased choline incorporation. Incor-
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Fig. 5. Effects of unilateral nephrectomy in donor rats on the ability of
the donor urine to stimulate thymidine incorporation into renal DNA in
rat bioassay. Results are shown as the ratio of the response to the one-
kidney donor's urine to the response to a two-kidney (sham-nephrecto-
my) donor's urine. Numbers of pairs at each time period are shown in
parentheses.
poration rates were 788 99 cpm per mg protein per 30 mm
incubation for urine-infused rats compared with 648 64 for
saline-infused rats (P < 0.025).
Effects of ultrafiltration of urine on choline incorporation.
Ultrafiltration fractions of urine were assayed for their ability to
stimulate choline incorporation into renal phospholipid, using 3-
hr infusions as above. The results are shown in Figure 6.
Stimulatory activity was evident in 10 of 12 assays of the
fraction retained on an XM5O membrane, the mean incorpo-
ration rate in the retentate-infused rats being 27% greater than
that of the saline-infused controls (P < 0.01). However, activity
was not demonstrable in either of the fractions that passed
through an XM5O membrane.
Choline incorporation in isolated renal tissue. These experi-
ments were designed to examine the ability of urine fractions to
directly stimulate choline incorporation into phospholipid in
renal tissue. Because activity with regard to stimulation of
phospholipid synthesis appeared to reside largely in the XM5O
retentate (see above), these studies were confined to this
retentate. Fresh cortical fragments from kidneys of normal rats
were pre-incubated with varying concentrations of retentate for
2 hr, during the final 30 mm of which ['4C]-choline was added.
Choline incorporation into phospholipid is shown in Figure 7 as
a function of "dose" of retentate from 0.20 to 5.12 min/ml.
There was minimal response at doses of 0.20 and 0.40 min/m!,
with a marked increase in activity at a dose of 0.80 mm/mI (P <
0.005). Above 0.80 min/rnl, there was a reduction in stimulation
with increased dose. The general configuration of the dose-
response curve was sigmoid but with progressive attenuation of
response in the higher dose range. Liver tissue samples were
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Fig. 6. Rates of incorporation of [14C/-choline into renal cortical
phospholipid in bioassay rats, in response io3-hr infusions of various
ultrafiltration fractions of urine. Arrows indicate means. The P value
refers to the difference between the urine-infused and saline-infused
means.
similarly tested for their ability to respond to XM5O retentate,
over the same dose range as for kidney tissue, above. There
was no change in choline incorporation rate in the liver tissue at
any dose.
Discussion
We have reported previously that the process of half-urine-
reinfusion, a procedure that selectively halves urinary excre-
tory function, is capable of stimulating renal protein synthesis
[3]. This result has suggested that the circulatory retention of
renal-growth-stimulating, or "renotrophic" factors that are
excreted normally in the urine can provide a stimulus for renal
growth. in this study, we examined the following questions:
Can these urinary renotrophic factors stimulate renal growth as
manifest by biochemical changes other than protein synthesis?
Can these factors be transferred from one rat to another? Do
these factors originate in the kidney, or at a nonrenal site? Do
these factors stimulate renal growth by direct action on renal
tissue, or is their action indirect?
Renal DNA synthesis. In these studies, haif-urine-reinfusion
for 24 hr resulted in a modest though significant increase in
whole-kidney DNA content. More strikingly, the incorporation
rate of tritiated thymidine into renal DNA in vitro was increased
some twofold in comparison with sham-manipulated controls, a
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Fig. 7. Direct stimulation of renal tissue: effect on incorporation of
['4C]-choline into phospholipid of cortical fragments incubated in
varying concentrations of XM5O retentate of urine. Responses are
expressed as the differences between tissue incubated in retentate and
that incubated without retentate. *Concentration is expressed as the
duration of the urine collection time (mm) represented in the amount of
retentate, per milliliter of incubation medium.
degree of increase considerably greater than that of the incorpo-
ration of leucine into renal protein previously reported [3].
Accordingly, thymidine incorporation into DNA was subse-
quently used as the major index of renal growth stimulation in
the bioassay method in these studies.
The haif-urine-reinfusion experiments both in this and earlier
studies [2, 3] have suggested the presence of renotrophic factors
in rat urine. However, to definitely establish the presence of
such factors, it is necessary to demonstrate that urine, or an
extract thereof, from one animal is capable of stimulating
growth in the renal tissue of another animal. Therefore, the
observation that a 24-hr infusion of urine from donor rats
produced a consistent increase in thymidine incorporation into
renal DNA in assay rats (Fig. 1) was a major finding of this
study.
The increase in thymidine incorporation is suggestive of,
although not proof of, an increase in renal DNA synthesis rate.
Increased incorporation of a labelled precursor can also be
influenced by the size of intracellular precursor pools. To more
clearly define the degree to which the increased thymidine
incorporation might reflect an actual increase in DNA synthe-
sis, we examined the effects of urine-infusion on the uptake of
tritiated thymidine into renal cortical cells. The results (Fig. 2)
indicate that urine-infusion produced no significant change in
the rate of thymidine accumulation in cortical cells. Moreover,
although complete equilibration between extracellular and in-
tracellular thymidine concentrations was not attained in the 60-
mm incubation period used, the uptake curves in Figure 2
strongly suggest that intracellular thymidine concentrations in
the urine-infused and saline-infused models did not differ from
each other. Thus, it seems unlikely that the increased incorpo-
ration of tritiated thymidine into renal DNA in the urine-infused
rats was due to a smaller intracellular thymidine pool (that is,
decreased dilution of tracer by unlabelled thymidine). Rather,
these data suggest that increased thymidine incorporation in the
urine-infused rats was a manifestation of increased DNA
synthesis.
According to Toback, Smith, and Lowenstein [5], renal
phospholipid synthesis, as evidenced by labelled choline incor-
poration in kidney slices, increases within 5 mm of contralateral
nephrectomy in mice. This increase in phospholipid synthesis
presumably reflects the synthesis of new cell membranes and is
an early manifestation of growth in the remaining kidney. In
these studies, we examined whether or not a similar stimulation
of renal phospholipid synthesis might be produced by urinary
renotrophic factors, using a urine-infusion assay similar to that
in which thymidine incorporation was measured (Fig. 1). Be-
cause of the rapidity of the response reported by Toback,
Smith, and Lowenstein with respect to phospholipid synthesis
[51, we infused urine into assay rats for only 3 hr instead of 24,
then measured ['4C]-choline incorporation into renal phospho-
lipid. The finding of an increase, averaging approximately 22%,
in the urine-infused rats, suggests that renal phospholipid
synthesis can be stimulated by urinary factors. These data,
along with the finding of stimulation of renal DNA synthesis by
urine-infusion, further support the presence of renotrophic
factors that are excreted normally in the urine.
Origin of urinary renotrophic factors. Although renotrophic
factors appear to be present in urine, our data have not, in
themselves, suggested the origin of these factors. It is possible
that these urinary factors are synthesized at a site other than the
kidneys, are normally present in the circulation, and are cleared
from the blood by urinary excretion. Alternatively, they might
be synthesized by the kidneys and excreted in the urine,
without being present in the circulation. To attempt to distin-
guish between these possibilities, we compared urine samples
from donor rats with one versus two kidneys for their ability to
stimulate renal DNA synthesis.
The results (Fig. 5) indicate that, for the first 2 days after
uninephrectomy, the renotrophic activity of urine from a one-
kidney donor was modestly (20 to 21%) reduced. After 2 days,
there was no difference between one- and two-kidney rats in the
renotrophic activity of their urine. If the renotrophic activity
was due to noncirculating factors synthesized solely in the
kidney itself, the removal of one kidney would be expected to
produce a distinct and persistent decrease—in theory, a halv-
ing—of excretion of the factors. The pattern observed, howev-
er, of a decrease that was modest and transient, is much more
suggestive of circulating factors synthesized at nonrenal sites,
and cleared from the circulation by urinary excretion.
Characteristics of urinary renotrophic factors. Previously,
we reported evidence that urinary renotrophic factors were not
readily dialyzable [3], a finding that indicates that the renal
growth stimulation in those studies was not due to small
molecular weight urinary solutes, such as urea, ammonia, acid,
or amino acids. This finding is further supported by the present
observations that UM1O ultrafiltrate (nominally less than 10,000
daltons) of urine shows no evidence of renotrophic activity,
whereas larger molecular size urine fractions exhibit significant
activity (Figs. 4 and 6).
Renotrophic activity was evident in the XM5O retentate
(nominally greater than 50,000 daltons) both in the bioassay
using DNA synthesis and phospholipid synthesis. However, in
the fraction that passed through an XM5O but was retained on a
UM1O membrane, activity was clearly detectable by DNA
synthesis (Fig. 4), but not by phospholipid synthesis (Fig. 6).
The reasons for this difference are not clear. It is possible that
P <0.005
(8)
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different factors, with differing molecular sizes, stimulate the
synthesis of DNA and phospholipid. On the other hand, it is
possible that the two different assay systems detect the same
factor but with different degrees of sensitivity. For example, in
the assays of unmodified urine, thymidine incorporation was
increased approximately twofold (Fig. 1), whereas choline
incorporation was increased by about 22%. Thus, the greater
sensitivity of the assay using DNA synthesis may permit
detection of a level of renotrophic activity in the 10,000 to
50,000 dalton fraction that is below the sensitivity of the assay
using phospholipid synthesis.
The fact that the major portion of renotrophic activity, by
either assay, resides in the XM5O retentate would appear to
pose a difficulty for the postulate that the renotrophic factors
are of circulatory origin. If the factors indeed had a molecular
size greater than 50,000 daltons, their clearance by glomerular
filtration would be relatively slow [8], such that a reduction in
urinary excretory function would hardly be expected to result in
a rapid or substantial rise in circulatory levels of the factors. It
is quite possible, however, that the renotrophic factors in the
XM5O retentate are smaller than 50,000 daltons. For instance,
the manufacturer's published specifications for Diaflo mem-
branes describes 85% retention of alpha-chymotrypsin (24,500
daltons) by the XM5O membrane. In addit-ion, it is conceivable
that a renotrophic factor of intermediate size, say, between
10,000 and 20,000 daltons, might exist as a free molecule in the
plasma and glomerular filtrate, but undergo polymerization or
binding to a larger protein molecule in the urine and thus display
the ultrafiltration characteristics of a large molecule.
The finding that most of the urinary renotrophic activity
resists heating to 100°C for 30 mm would appear to reduce the
likelihood that the factors are large molecular weight proteins.
Although the molecular size of the urinary renotrophic fac-
tors remains to be established, the present data, along with the
earlier observation of poor dialyzability [3], strongly support
the concept that these factors are not small molecules. As
pointed out previously [3], the fact that the renotrophic factors
are probably too large to be readily transferable across the
epithelium of the peritoneum or gut might explain why earlier
experimental "urinary diversion" models, such as drainage of
one ureter into the gastrointestinal tract [9] or peritoneal cavity
[10—14] did not result in renal growth.
Direct stimulation of renal tissue. Our data, thus far, have not
indicated whether the renotrophic factors suggested by our
findings stimulate renal growth by direct action on the kidney,
or by some indirect action, such as initiating the secretion by
another organ of a factor that would, in turn, directly act on the
kidney. The present data (Fig. 7) suggest that, with regard to the
stimulation of phospholipid synthesis, at least part of the action
is direct. By incubating isolated renal cortical tissue in varying
concentrations of XM5O retentate, a sigmoid dose-response
curve was obtained for changes in choline incorporation rates.
The reasons for attenuation of response in the higher dose range
of the curve are not clear. Conceivably, this attenuation might
reflect the presence of a growth inhibitor in the XM5O retentate,
whose action would only become manifest in higher concentra-
tions. However, such a possibility remains to be examined.
Previously, we reported that the process of half-urine-reinfu-
sion, while significantly stimulating renal protein synthesis, had
no detectable effect on protein synthesis by the liver [3]. In the
present experiments, we found that urine-reinfusion stimulates
renal, but not hepatic, thymidine incorporation into DNA, and
that the XM5O retentate of urine appears to act directly on
isolated renal, but not hepatic, tissue to increase choline
incorporation into phospholipid. Thus, the present data further
substantiate the conclusion that urinary renotrophic factors are
specific for kidney tissue to the extent that hepatic growth is not
stimulated.
The question naturally arises as to whether the renal growth
stimulated by urinary renotrophic factors is biologically equiva-
lent to that which follows renal ablation. The "compensatory"
growth in the latter instance does not appear to be characterized
by either biochemical or morphological features that would
enable it to be clearly distinguished from other forms of renal
growth. Indeed, there are many experimental manipulations
capable of stimulating renal growth [1], but the physiological
relevance of renal growth induced by these maneuvers to
compensatory renal growth remains to be defined. In like
manner, the fact that renal growth can be stimulated by urinary
factors does not establish that these factors are responsible for
renal growth after renal ablation. At this point, it can only be
stated that our data thus far suggest a variety of similarities
between the renal growth induced by urinary factors and that
induced by renal ablation. Half-urine-infusion and uninephrec-
tomy have been shown to result in comparable increases in
renal mass after 1 week [2] and in renal protein synthesis after
24 hr [3]. These studies indicate that urine-infusion leads to an
increase in thymidine incorporation into renal DNA at 24 hr
similar to that described after uninephrectomy by Toback and
Lowenstein [15]. In addition, the increases in renal incorpo-
ration of choline into phospholipid appear to be comparable
between the present urine-infused rats and the uninephrectomy
model of Toback, Smith, and Lowenstein [51.
The relationship between the urinary renotrophic factors
suggested by our data and the circulating renotrophic factors
suggested by the data of other investigators [16—21] remains to
be clarified. For the most part, the physicochemical character-
istics of these circulating factors have not been examined. Where
tested, the renotrophic activity of plasma from nephrectomized
rats [16, 21] or hamsters [20] was not removed by dialysis.
Aside from this similarity to the urinary factors described in our
studies, comparisons are difficult to make and will have to await
more refined characterization of both the urinary and the
circulating factors.
Summary
Our previous observations of increased renal protein synthe-
sis in rats subjected to the constant intravenous reinfusion of
half their urine output has suggested that the circulatory reten-
tion of renotrophic factors in urine is capable of stimulating
renal growth. In the present studies, using this same model of
"half-urine-reinfusion," which is designed to produce a selec-
tive halving of renal excretory function, we have demonstrated
significant increases in total DNA content and the incorporation
of tritiated thymidine in renal DNA. In addition, a bioassay
method was developed in which an assay rat, given an intrave-
nous infusion of urine from another rat, exhibited increases in
the incorporation of thymidine into renal DNA and the incorpo-
ration of radiolabelled choline into renal phospholipid. This
renotrophic activity in the urine was only minimally decreased
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by heating to 100°C for 30 mm and was confined to ultrafiltra-
tion fractions retained on a membrane with a nominal 10,000-
dalton solute rejection. Removal of one kidney from the rats
from which the urine was obtained led to only a modest and
transient reduction in the excretion of renotrophic activity,
suggesting that the urinary renotrophic factors are of circula-
tory, not renal, origin. Isolated renal cortical fragments incubat-
ed with an ultrafiltration retentate of urine displayed a dose-
dependent increase in choline incorporation into phospholipid,
suggesting a direct action of the factors on kidney tissue.
Finally, no evidence of stimulation of either DNA or phospho-
lipid synthesis could be seen in hepatic tissue.
In conclusion, our data support the concept that there are
renotrophic factors normally excreted in urine; that these
factors are capable of stimulating renal synthesis of protein,
DNA, and phospholipid; that the factors are of medium to large
molecular size and are largely heat-stable; that they appear to
have extra-renal origin(s); and that they are specific for the
kidney to the extent that they do not stimulate hepatic growth.
Retention of these factors may provide an important stimulus to
renal growth following ablation of renal mass.
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